ABN 16 165 160 841 +61 (0) 3 9123 1140 | info@ampliatx.com Level 5, 90 William Street, Melbourne VIC 3000 Australia www.ampliatx.com 28 AUGUST 2026 ASX RELEASE CEO & MANAGING DIRECTOR’S PRESENTATION TO ANNUAL GENERAL MEETING Melbourne, Australia: Amplia Therapeutics...
CEO Managing Director Presentation to Annual General Meeting
Filed with ASX · · 19 pages · English
Release
Amplia Therapeutics Ltd. on 6ix
In the deck
Earlier from Amplia Therapeutics
- Bioshares Biotech Summit Presentation
- Amplia signs Collaboration and Supply Agreement with Lilly
- Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
- Scientific Paper Studies of narmafotinib - Pancreatic Cancer
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Amplia Therapeutics
- Results of Annual General Meeting
- Notification regarding unquoted securities - ATX
- Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial
- Amplia Presents at E&P Healthcare Conference 2026
- Amplia Presents at CG Drug and Device Conference 2026
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics